tiprankstipranks
MiniMed Group, Inc. (MMED)
NASDAQ:MMED
US Market
MMED
MiniMed Group, Inc.
RESEARCH TOOLSreports

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

41 Followers
See the Price Targets and Ratings of:

MMED Analyst Ratings

Strong Buy
13Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
Based on 13 analysts giving stock ratings to
MiniMed
Group, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MMED Stock 12 Month Forecast

Average Price Target

$21.08
▲(45.96% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for MiniMed Group, Inc. in the last 3 months. The average price target is $21.08 with a high forecast of $26.00 and a low forecast of $14.00. The average price target represents a 45.96% change from the last price of $14.44.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","15":"$15","19":"$19","23":"$23","27":"$27"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$26.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.076923076923077,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$21.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,15,19,23,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,13.076923076923077,14.153846153846153,15.23076923076923,16.307692307692307,17.384615384615383,18.46153846153846,19.53846153846154,20.615384615384613,21.692307692307693,22.769230769230766,23.846153846153847,24.923076923076923,{"y":26,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.698224852071005,13.396449704142011,14.094674556213018,14.792899408284024,15.49112426035503,16.189349112426036,16.887573964497044,17.585798816568047,18.28402366863905,18.98224852071006,19.680473372781066,20.378698224852073,{"y":21.076923076923077,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.153846153846153,12.307692307692308,12.461538461538462,12.615384615384615,12.76923076923077,12.923076923076923,13.076923076923077,13.23076923076923,13.384615384615385,13.538461538461538,13.692307692307693,13.846153846153847,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.49,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.48,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.11,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$26.00Average Price Target$21.08Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on MMED
Larry Biegelsen
Wells Fargo
Wells Fargo
$22→$26
Buy
80.06%
Upside
Reiterated
06/08/26
Wells Fargo Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)
Bank of America Securities Analyst forecast on MMED
Travis Steed
Bank of America Securities
Bank of America Securities
$20
Buy
38.50%
Upside
Reiterated
06/08/26
Analyst Reiterates Buy on MMED, Sees Favorable Risk/Reward with Unchanged $20 Price Target
Evercore ISI Analyst forecast on MMED
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$20
Buy
38.50%
Upside
Reiterated
06/05/26
Evercore ISI Remains a Buy on MiniMed Group, Inc. (MMED)
Morgan Stanley Analyst forecast on MMED
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$14.06→$19
Buy
31.58%
Upside
Reiterated
06/05/26
Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)
Piper Sandler Analyst forecast on MMED
Matthew O'Brien
Piper Sandler
Piper Sandler
$16
Hold
10.80%
Upside
Reiterated
06/04/26
Piper Sandler Reaffirms Their Hold Rating on MiniMed Group, Inc. (MMED)
BTIG Analyst forecast on MMED
Marie Thibault
BTIG
BTIG
$25
Buy
73.13%
Upside
Reiterated
06/04/26
MMED Buy Rating Reiterated as Analyst Sees Strong Fundamentals, FY27 Catalysts and Upside to Unchanged $25 Price Target
Mizuho Securities Analyst forecast on MMED
Anthony Petrone
Mizuho Securities
Mizuho Securities
$21
Buy
45.43%
Upside
Reiterated
06/03/26
Analysts Offer Insights on NA Companies: MiniMed Group, Inc. (NASDAQ: MMED) and Janus Living, Inc. Class A (NYSE: JAN)
Citi Analyst forecast on MMED
Joanne Wuensch
Citi
Citi
$23
Buy
59.28%
Upside
Reiterated
06/03/26
Citi Remains a Buy on MiniMed Group, Inc. (MMED)
Goldman Sachs Analyst forecast on MMED
David Roman
Goldman Sachs
Goldman Sachs
$14.01→$24
Buy
66.20%
Upside
Reiterated
06/03/26
David Roman Lifts MiniMed Price Target to $24, Citing Strong Growth, Margin Outperformance and Compelling Valuation
Benchmark Co. Analyst forecast on MMED
Bruce Jackson
Benchmark Co.
Benchmark Co.
$20
Buy
38.50%
Upside
Reiterated
06/03/26
Benchmark Co. Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)
William Blair Analyst forecast on MMED
Steven Lichtman
William Blair
William Blair
$14
Buy
-3.05%
Downside
Initiated
03/31/26
MiniMed initiated with an Outperform at William BlairMiniMed initiated with an Outperform at William Blair
Deutsche Bank Analyst forecast on MMED
Pito Chickering
Deutsche Bank
Deutsche Bank
$20
Buy
38.50%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank
Barclays Analyst forecast on MMED
Matt Miksic
Barclays
Barclays
$26
Buy
80.06%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on MMED
Larry Biegelsen
Wells Fargo
Wells Fargo
$22→$26
Buy
80.06%
Upside
Reiterated
06/08/26
Wells Fargo Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)
Bank of America Securities Analyst forecast on MMED
Travis Steed
Bank of America Securities
Bank of America Securities
$20
Buy
38.50%
Upside
Reiterated
06/08/26
Analyst Reiterates Buy on MMED, Sees Favorable Risk/Reward with Unchanged $20 Price Target
Evercore ISI Analyst forecast on MMED
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$20
Buy
38.50%
Upside
Reiterated
06/05/26
Evercore ISI Remains a Buy on MiniMed Group, Inc. (MMED)
Morgan Stanley Analyst forecast on MMED
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$14.06→$19
Buy
31.58%
Upside
Reiterated
06/05/26
Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)
Piper Sandler Analyst forecast on MMED
Matthew O'Brien
Piper Sandler
Piper Sandler
$16
Hold
10.80%
Upside
Reiterated
06/04/26
Piper Sandler Reaffirms Their Hold Rating on MiniMed Group, Inc. (MMED)
BTIG Analyst forecast on MMED
Marie Thibault
BTIG
BTIG
$25
Buy
73.13%
Upside
Reiterated
06/04/26
MMED Buy Rating Reiterated as Analyst Sees Strong Fundamentals, FY27 Catalysts and Upside to Unchanged $25 Price Target
Mizuho Securities Analyst forecast on MMED
Anthony Petrone
Mizuho Securities
Mizuho Securities
$21
Buy
45.43%
Upside
Reiterated
06/03/26
Analysts Offer Insights on NA Companies: MiniMed Group, Inc. (NASDAQ: MMED) and Janus Living, Inc. Class A (NYSE: JAN)
Citi Analyst forecast on MMED
Joanne Wuensch
Citi
Citi
$23
Buy
59.28%
Upside
Reiterated
06/03/26
Citi Remains a Buy on MiniMed Group, Inc. (MMED)
Goldman Sachs Analyst forecast on MMED
David Roman
Goldman Sachs
Goldman Sachs
$14.01→$24
Buy
66.20%
Upside
Reiterated
06/03/26
David Roman Lifts MiniMed Price Target to $24, Citing Strong Growth, Margin Outperformance and Compelling Valuation
Benchmark Co. Analyst forecast on MMED
Bruce Jackson
Benchmark Co.
Benchmark Co.
$20
Buy
38.50%
Upside
Reiterated
06/03/26
Benchmark Co. Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED)
William Blair Analyst forecast on MMED
Steven Lichtman
William Blair
William Blair
$14
Buy
-3.05%
Downside
Initiated
03/31/26
MiniMed initiated with an Outperform at William BlairMiniMed initiated with an Outperform at William Blair
Deutsche Bank Analyst forecast on MMED
Pito Chickering
Deutsche Bank
Deutsche Bank
$20
Buy
38.50%
Upside
Initiated
03/31/26
MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank
Barclays Analyst forecast on MMED
Matt Miksic
Barclays
Barclays
$26
Buy
80.06%
Upside
Initiated
03/31/26
MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MiniMed Group, Inc.

3 Months
Travis SteedBank of America Securities
Success Rate
2/3 ratings generated profit
67%
Average Return
+14.10%
Copying Travis Steed's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +14.10% per trade.
1 Year
Travis SteedBank of America Securities
Success Rate
2/3 ratings generated profit
67%
Average Return
+14.10%
Copying Travis Steed's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +14.10% per trade.
2 Years
Travis SteedBank of America Securities
Success Rate
2/3 ratings generated profit
67%
Average Return
+14.10%
Copying Travis Steed's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +14.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MMED Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
5
5
9
9
Buy
0
6
7
7
7
Hold
0
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
12
13
17
17
In the current month, MMED has received 16 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MMED average Analyst price target in the past 3 months is 21.08.
Each month's total comprises the sum of three months' worth of ratings.

MMED Financial Forecast

MMED Earnings Forecast

Next quarter’s earnings estimate for MMED is -$0.15 with a range of -$0.26 to $0.24. The previous quarter’s EPS was -$0.68. MMED beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year MMED has its overall industry.
Next quarter’s earnings estimate for MMED is -$0.15 with a range of -$0.26 to $0.24. The previous quarter’s EPS was -$0.68. MMED beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year MMED has its overall industry.

MMED Sales Forecast

Next quarter’s sales forecast for MMED is $828.61M with a range of $823.80M to $837.00M. The previous quarter’s sales results were $837.00M. MMED beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year MMED has its overall industry.
Next quarter’s sales forecast for MMED is $828.61M with a range of $823.80M to $837.00M. The previous quarter’s sales results were $837.00M. MMED beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year MMED has its overall industry.

MMED Stock Forecast FAQ

What is MMED’s average 12-month price target, according to analysts?
Based on analyst ratings, MiniMed Group, Inc.’s 12-month average price target is 21.08.
    What is MMED’s upside potential, based on the analysts’ average price target?
    MiniMed Group, Inc. has 45.96% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MMED a Buy, Sell or Hold?
          MiniMed Group, Inc. has a consensus rating of Strong Buy which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
            What is MiniMed Group, Inc.’s price target?
            The average price target for MiniMed Group, Inc. is 21.08. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $26.00 ,the lowest forecast is $14.00. The average price target represents 45.96% Increase from the current price of $14.44.
              What do analysts say about MiniMed Group, Inc.?
              MiniMed Group, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of MMED?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.